Your browser doesn't support javascript.
loading
OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response.
Jacquemin, Clément; Schmitt, Nathalie; Contin-Bordes, Cécile; Liu, Yang; Narayanan, Priya; Seneschal, Julien; Maurouard, Typhanie; Dougall, David; Davizon, Emily Spence; Dumortier, Hélène; Douchet, Isabelle; Raffray, Loïc; Richez, Christophe; Lazaro, Estibaliz; Duffau, Pierre; Truchetet, Marie-Elise; Khoryati, Liliane; Mercié, Patrick; Couzi, Lionel; Merville, Pierre; Schaeverbeke, Thierry; Viallard, Jean-François; Pellegrin, Jean-Luc; Moreau, Jean-François; Muller, Sylviane; Zurawski, Sandy; Coffman, Robert L; Pascual, Virginia; Ueno, Hideki; Blanco, Patrick.
Afiliação
  • Jacquemin C; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France.
  • Schmitt N; Baylor Institute for Immunology Research, Dallas, TX 75204, USA.
  • Contin-Bordes C; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
  • Liu Y; Baylor Institute for Immunology Research, Dallas, TX 75204, USA.
  • Narayanan P; Baylor Institute for Immunology Research, Dallas, TX 75204, USA.
  • Seneschal J; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
  • Maurouard T; Baylor Institute for Immunology Research, Dallas, TX 75204, USA.
  • Dougall D; Baylor Institute for Immunology Research, Dallas, TX 75204, USA.
  • Davizon ES; Baylor Institute for Immunology Research, Dallas, TX 75204, USA.
  • Dumortier H; CNRS, Immunopathology and therapeutic chemistry/Laboratory of excellence MEDALIS, Institut de Biologie Moléculaire et Cellulaire;University of Strasbourg, F-67081 Strasbourg, France.
  • Douchet I; CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France.
  • Raffray L; CHU de Bordeaux, F-33076 Bordeaux, France.
  • Richez C; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
  • Lazaro E; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
  • Duffau P; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
  • Truchetet ME; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
  • Khoryati L; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France.
  • Mercié P; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
  • Couzi L; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
  • Merville P; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
  • Schaeverbeke T; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
  • Viallard JF; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
  • Pellegrin JL; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
  • Moreau JF; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
  • Muller S; CNRS, Immunopathology and therapeutic chemistry/Laboratory of excellence MEDALIS, Institut de Biologie Moléculaire et Cellulaire;University of Strasbourg, F-67081 Strasbourg, France; University of Strasbourg Institute for Advanced Study, F-67081 Strasbourg, France.
  • Zurawski S; Baylor Institute for Immunology Research, Dallas, TX 75204, USA.
  • Coffman RL; Dynavax Technologies Corporation, Berkeley, CA 94710, USA.
  • Pascual V; Baylor Institute for Immunology Research, Dallas, TX 75204, USA.
  • Ueno H; Baylor Institute for Immunology Research, Dallas, TX 75204, USA. Electronic address: hidekiu@baylorhealth.edu.
  • Blanco P; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France; Baylor Institute for Immunology Research, Dallas, TX 75204, USA; CHU de Bordeaux, F-33076 Bordeaux, France. Electronic address: patrick.blanco@chu-bordeaux.fr.
Immunity ; 42(6): 1159-70, 2015 Jun 16.
Article em En | MEDLINE | ID: mdl-26070486
ABSTRACT
Increased activity of T follicular helper (Tfh) cells plays a major pathogenic role in systemic lupus erythematosus (SLE). However, the mechanisms that cause aberrant Tfh cell responses in SLE remain elusive. Here we showed the OX40 ligand (OX40L)-OX40 axis contributes to the aberrant Tfh response in SLE. OX40L was expressed by myeloid antigen-presenting cells (APCs), but not B cells, in blood and in inflamed tissues in adult and pediatric SLE patients. The frequency of circulating OX40L-expressing myeloid APCs positively correlated with disease activity and the frequency of ICOS(+) blood Tfh cells in SLE. OX40 signals promoted naive and memory CD4(+) T cells to express multiple Tfh cell molecules and were sufficient to induce them to become functional B cell helpers. Immune complexes containing RNA induced OX40L expression on myeloid APCs via TLR7 activation. Our study provides a rationale to target the OX40L-OX40 axis as a therapeutic modality for SLE.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T Auxiliares-Indutores / Células Mieloides / Ligante OX40 / Receptores OX40 / Lúpus Eritematoso Sistêmico Tipo de estudo: Etiology_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T Auxiliares-Indutores / Células Mieloides / Ligante OX40 / Receptores OX40 / Lúpus Eritematoso Sistêmico Tipo de estudo: Etiology_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article